Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Rating of "Buy" from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has earned a consensus recommendation of "Buy" from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $29.11.

A number of equities analysts have issued reports on ASPN shares. Piper Sandler decreased their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating for the company in a report on Thursday. Roth Mkm dropped their price objective on Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research note on Friday, November 8th. Barclays reduced their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research note on Tuesday, November 12th. Finally, StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, November 13th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Lord Abbett & CO. LLC purchased a new stake in Aspen Aerogels in the 3rd quarter worth approximately $10,126,000. Oppenheimer & Co. Inc. raised its holdings in shares of Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock valued at $2,839,000 after acquiring an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC lifted its stake in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock worth $436,000 after acquiring an additional 27,000 shares during the period. Penserra Capital Management LLC bought a new stake in Aspen Aerogels in the third quarter valued at $1,342,000. Finally, Geode Capital Management LLC increased its position in Aspen Aerogels by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock valued at $38,385,000 after purchasing an additional 75,024 shares during the period. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Up 1.3 %

ASPN traded up $0.17 during midday trading on Monday, hitting $12.73. The company had a trading volume of 1,371,812 shares, compared to its average volume of 1,388,320. The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of 1,273.77 and a beta of 2.14. The stock's 50 day moving average price is $13.47 and its 200 day moving average price is $20.18. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 52 week low of $10.75 and a 52 week high of $33.15.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.